| 000 | 01682 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514023111.0 | ||
| 264 | 0 | _c20020626 | |
| 008 | 200206s 0 0 eng d | ||
| 022 | _a0378-6501 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPaczek, L | |
| 245 | 0 | 0 |
_aProtease administration decreases enhanced transforming growth factor-beta 1 content in isolated glomeruli of diabetic rats. _h[electronic resource] |
| 260 |
_bDrugs under experimental and clinical research _c2001 |
||
| 300 |
_a141-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBody Weight |
| 650 | 0 | 4 |
_aBromelains _xpharmacology |
| 650 | 0 | 4 |
_aCathepsin B _xmetabolism |
| 650 | 0 | 4 |
_aCollagenases _xmetabolism |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xcomplications |
| 650 | 0 | 4 |
_aDiabetic Nephropathies _xetiology |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 |
_aEndopeptidases _xadministration & dosage |
| 650 | 0 | 4 |
_aFibronectins _xmetabolism |
| 650 | 0 | 4 | _aKidney Function Tests |
| 650 | 0 | 4 |
_aKidney Glomerulus _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aOrgan Size |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aRutin _xanalogs & derivatives |
| 650 | 0 | 4 |
_aTransforming Growth Factor beta _xdrug effects |
| 650 | 0 | 4 | _aTransforming Growth Factor beta1 |
| 650 | 0 | 4 |
_aTrypsin _xpharmacology |
| 650 | 0 | 4 |
_aalpha-Macroglobulins _xmetabolism |
| 700 | 1 | _aGaciong, Z | |
| 700 | 1 | _aBartlomiejczyk, I | |
| 700 | 1 | _aSebekova, K | |
| 700 | 1 | _aBirkenmeier, G | |
| 700 | 1 | _aHeidland, A | |
| 773 | 0 |
_tDrugs under experimental and clinical research _gvol. 27 _gno. 4 _gp. 141-9 |
|
| 999 |
_c11731946 _d11731946 |
||